BRIDGEWAY CAPITAL MANAGEMENT, LLC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 17 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q1 2017$228,000
-32.1%
361,200
-18.1%
0.00%
-25.0%
Q4 2016$336,000
-56.3%
440,805
-1.4%
0.00%
-63.6%
Q3 2016$769,000
-26.4%
446,978
-23.0%
0.01%
-31.2%
Q2 2016$1,045,000
-23.8%
580,8050.0%0.02%
-30.4%
Q1 2016$1,371,000
+163.7%
580,805
+155.6%
0.02%
+130.0%
Q4 2015$520,000
+0.8%
227,2050.0%0.01%
-9.1%
Q3 2015$516,000
+260.8%
227,205
+354.4%
0.01%
+266.7%
Q2 2015$143,000
+101.4%
50,000
+25.0%
0.00%
+50.0%
Q3 2014$71,000
+2.9%
40,0000.0%0.00%0.0%
Q2 2014$69,000
-33.0%
40,0000.0%0.00%
-33.3%
Q1 2014$103,000
+68.9%
40,0000.0%0.00%
+50.0%
Q4 2013$61,000
-54.5%
40,000
-50.0%
0.00%
-60.0%
Q3 2013$134,000
-2.9%
80,0000.0%0.01%
-16.7%
Q2 2013$138,00080,0000.01%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,734,149$6,609,00011.59%
Third Security, LLC 13,238,268$22,770,0001.06%
MSD Partners, L.P. 3,118,402$5,364,0000.43%
EDMOND DE ROTHSCHILD (SUISSE) S.A. 290,000$499,0000.15%
BARD ASSOCIATES INC 93,299$160,0000.08%
FRANKLIN STREET ADVISORS INC /NC 126,000$217,0000.04%
BLAIR WILLIAM & CO/IL 1,998,886$3,438,0000.03%
HAMILTON LANE ADVISORS LLC 23,855$41,0000.02%
Sheaff Brock Investment Advisors, LLC 86,449$149,0000.02%
Rothschild Capital Partners, LLC 30,000$52,0000.02%
View complete list of SYNTHETIC BIOLOGICS INC shareholders